Table 2.
Outcome (%) | Pre- Implementation |
Early Implementation |
Full Implementation |
Non- enrolled |
ERAS vs. non-ERAS p |
Early vs. Late p |
---|---|---|---|---|---|---|
n=30 | n=10 | n=18 | n=8 | |||
Any complication | 17 | 40 | 11 | 25 | 0.277 | 0.147 |
Surgical site infection | 10 | 10 | 6 | 13 | 0.932 | 1.000 |
Pneumonia | 3 | 0 | 0 | 0 | 1.000 | 1.000 |
Reintubation | 0 | 0 | 0 | 11 | 0.121 | 1.000 |
Venothrombembolism | 3 | 0 | 0 | 0 | 1.000 | 1.000 |
Urinary tract infection | 3 | 0 | 6 | 0 | 1.000 | 1.000 |
Perioperative transfusion | 0 | 10 | 0 | 0 | 0.273 | 0.357 |
Sepsis | 3 | 20 | 6 | 0 | 0.214 | 0.284 |
Septic shock | 0 | 10 | 0 | 0 | 0.273 | 0.357 |
Length of stay (Median, IQR) | 5 (4 – 8) | 6 (5 – 7) | 5 (4 – 8) | 5 (4 – 7) | 0.921 | 0.554 |
Readmission | 7 | 40 | 17 | 38 | 0.029 | 0.207 |
Complications without events for any group excluded: anastomotic leak, acute renal failure, coma, cerebrovascular accident, peripheral nerve injury, cardiac arrest, and death.